-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
L-Lysine-13C6,15N2,d9 dihydrochloride
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1994268-57-32d.gif)
| Category | Virus Protease |
| CAS | 1994268-57-3 |
| Description | L-Lysine-[13C6,15N2,d9] Dihydrochloride is the labelled analogue of L-Lysine Dihydrochloride, which is a naturally occurring amino acid used in the labelling of human bone marrow mesenchymal stem cells for analysis. |
Product Information
| Synonyms | HY-N0470S1;CS-0375823;L-Lysine-13C6,15N2,d9 (dihydrochloride);L-Lysine-13C6,d9,15N2 (dihydrochloride);L-Lysine:2Hcl (13C6, 97-99%; D9, 97-99%; 15N2, 97-99%);1994268-57-3; |
| IUPAC Name | (2S)-2,6-bis(15N)(azanyl)-2,3,3,4,4,5,5,6,6-nonadeuterio(1,2,3,4,5,6-13C6)hexanoic acid;dihydrochloride |
| Molecular Weight | 198.17 |
| Molecular Formula | C9H10O5 |
| Canonical SMILES | C1=CC(=C(C=C1C[C@H](C(=O)O)O)O)O |
| InChI | InChI=1S/C6H14N2O2.2ClH/c7-4-2-1-3-5(8)6(9)10;;/h5H,1-4,7-8H2,(H,9,10);2*1H/t5-;;/m0../s1/i1+1D2,2+1D2,3+1D2,4+1D2,5+1D,6+1,7+1,8+1;; |
| InChIKey | JBBURJFZIMRPCZ-TZMBPQDKSA-N |
| Purity | 98% by CP; 97% atom 13C; 97% atom 15N; 97% atom D |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
